Efavirenz-Induced Decrease in Plasma Amprenavir Levels in Human Immunodeficiency Virus-Infected Patients and Correction by Ritonavir

Παρόμοια τεκμήρια

• Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with Ritonavir
  ανά: Duval, Xavier, κ.ά.
  Έκδοση: (2002)
• Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
  ανά: Marcelin, Anne-Geneviève, κ.ά.
  Έκδοση: (2003)
• Kinetics of Antiviral Activity and Intracellular Pharmacokinetics of Human Immunodeficiency Virus Type 1 Protease Inhibitors in Tissue Culture
  ανά: Nascimbeni, Michelina, κ.ά.
  Έκδοση: (1999)
• Amprenavir and Efavirenz Pharmacokinetics before and after the Addition of Nelfinavir, Indinavir, Ritonavir, or Saquinavir in Seronegative Individuals
  ανά: Morse, Gene D., κ.ά.
  Έκδοση: (2005)
• Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
  ανά: Marcelin, Anne-Geneviève, κ.ά.
  Έκδοση: (2004)